SPASTICITY. DIAGNOSIS AND MANAGEMENT. 2ND EDITION

PART I. GENERAL OVERVIEW
1. Why Is Spasticity Treatment Important?
2. Epidemiology of Spasticity in the Adult and Child
3. Spasticity and Other Signs of the Upper Motor Neuron Syndrome
4. Ancillary Findings Associated With Spasticity
PART II. ASSESSMENT TOOLS
5. Measurement Tools and Treatment Outcomes in Patients With Spasticity
6. Techniques and Scales for Measuring Spastic Paresis
7. Assessment of Spasticity in the Upper Extremity
8. Assessment of Lower Limb Spasticity and Other Consequences of the Upper Motor Neuron Syndrome
9. Setting Realistic and Meaningful Goals for Treatment
PART III. TREATMENT OF SPASTICITY
10. Chemoneurolysis With Phenol and Alcohol: A “Dying Art” That Merits Revival
11. Botulinum Toxin in the Treatment of Lower Limb Spasticity
12. Botulinum Toxin in the Treatment of Upper Limb Spasticity
13. Guidance Techniques for Botulinum Toxin Injections: A Comparison
14. Anatomical Correlation of Common Patterns of Spasticity
15. The Role of Physical and Occupational Therapy in the Evaluation and Management of Spasticity
16. Emerging Technologies in the Management of Upper Motor Neuron Syndromes
17. Effects of Noninvasive Neuromodulation in Spasticity
18. Pharmacologic Management of Spasticity: Oral Medications
19. Intrathecal Baclofen for Spasticity
20. Surgery in the Management of Spasticity
PART IV. EVALUATION AND MANAGEMENT OF DISEASES WITH SPASTICITY
21. Diagnostic Evaluation of Adult Patients With Spasticity
22. Overview of Genetic Causes of Spasticity in Adults and Children
23. Spasticity Due to Disease of the Spinal Cord: Pathophysiology, Epidemiology, and Treatment
24. Spasticity Due to Multiple Sclerosis: Epidemiology, Pathophysiology, and Treatment
25. Poststroke Spasticity Management With Botulinum Toxins and Intrathecal Baclofen
26. Management of Brain Injury Related Spasticity
27. Management of the Cancer Patient With Spasticity
28. Evaluation, Treatment Planning, and Nonsurgical Treatment of Cerebral Palsy
29. Surgical Management of Spasticity in the Child With Cerebral Palsy
30. Spasticity Management in Long-Term Care Facilities
31. Economic Impact of Spasticity and Its Treatment

Since publication of the first edition, Spasticity: Diagnosis and Management has been the defining reference and go-to source for physicians, therapists, and other healthcare providers who care for patients with spasticity. For this new updated edition, Dr. Brashear and a diverse team of specialists have come together to integrate new research, clinical trials, measurement tools, therapies, and other recent advances that reflect this evolving field.
The book is organized into four sections, each of which covers a broad scope of material. The first is a general overview of spasticity and its effects on movement in patients. Other chapters cover epidemiology and ancillary findings commonly associated with spasticity. Part II details assessment tools and measurements, treatment goals, and how to aim for realistic outcomes. Part III outlines various treatment modalities, including heavily updated chapters on the use of botulinum toxin in the upper and lower extremities, guidance techniques for injections, intrathecal baclofen, neuromodulation, surgery, physical therapy, and more. The last section, which contains several new chapters, discusses evaluation of outcomes and management of patients with stroke, traumatic brain injury, spinal cord injuries, multiple sclerosis, cerebral palsy, and cancer, followed by chapters on spasticity management in long-term care facilities and economic considerations.
This book remains the most comprehensive guide to diagnosis and management of spasticity in adults and children, and the revised second edition will continue to serve as an invaluable resource for professionals in any discipline who strive to provide quality care to spasticity patients.
Key Features:
• Revised edition of the premier clinical reference on spasticity
• Incorporates the latest advances in assessment and treatment
• Contains six entirely new chapters highlighting key topics including Tardieu scale and other measurement tools, ultrasound guidance for botulinum toxin management, spasticity in special populations, emerging therapies, and economic impact
• More than 200 figures and 70 tables accompany the updated text.

Authors
• Allison Brashear, MD, Professor and Chair, Department of Neurology, Wake Forest University School of Medicine/Baptist Medical Center, Winston-Salem, NC, USA.
• Elie Elovic, MD, Professor and Chief, Physical Medicine & Rehabilitation, University of Utah School of Medicine, Salt Lake City, UT, USA.